Related Experiment Video
Updated: Jul 13, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
[Cellular tumor markers in thyroid cancer].
Ewa Kopczyńska1, Justyna Kwapisz, Roman Junik
1Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum w Bydgoszczy, Katedra i Zakład Patobiochemii i Chemii Klinicznej. kopczynska@cm.umk.pl
Summary
Thyroid cancer, the most common endocrine malignancy, presents diagnostic challenges. Research explores circulating, cellular, and molecular markers to improve prognosis and treatment for patients with poor outcomes.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Context:
- Thyroid cancer is the most common endocrine malignancy, with varying patient prognoses.
- Current research focuses on advancing diagnostic methods for thyroid tumors.
Purpose:
- To review established and emerging cellular and molecular markers for thyroid cancer diagnosis and prognosis.
- To highlight the diagnostic and prognostic value of various thyroid tumor markers.
Summary:
- The review covers circulating markers (thyroglobulin, thyroid peroxidase, calcitonin, CEA) and cellular markers.
- Diagnostic markers like TSHR, RET Ras, BRAF, Met, and p53 are discussed.
- Prognostic markers (CD82, c-myc, Plk-1) and marker combinations (galectin-3, fibronectin, HBME-1) for differentiated thyroid cancer are presented.
Impact:
- Improved understanding of thyroid cancer markers aids in diagnosis and treatment stratification.
- Identifies key markers for assessing cancer aggressiveness and patient prognosis.
- Emphasizes the need for continued research into novel cellular thyroid markers.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...